Fludarabine in Alkylator-Resistant Follicular Non-Hodgkin's Lymphoma

References

• Armitage J. O., Weisenburger D. D. New Approach to Classifying Non-Hodgkin's Lymphomas: clinical features of the major histologic subtypes. Journal of Clinical Oncology 1998; 16(8)2780–2795
   PubMed Web of Science ®Google Scholar
• Horning S. J. Natural History of and Therapy for the Indolent Non-Hodgkin's Lymphoma. Seminars in Oncology 1993; 20(5)75–88
   PubMed Web of Science ®Google Scholar
• Hiddemanm W., Unterhalt M., Buske C., Sack H. Treatment of Follicular Centre Lymphomas: current status and future perspectives. Journal of Internal Medicine 1997; 242(supplement 740)55–62
   Google Scholar
• Dana B. W., Dahlberg S., Nathwani B. N., Chase E., Coltman C., Miller T. P., Fisher R. I. Long-Term Follow-Up of Patients with Low-Grade Malignant Lymphomas Treated With Doxirubicin-Based Chemotherapy or Chemoimmunotherapy. Journal of Clinical Oncology 1993; 11(4)644–651
   PubMed Web of Science ®Google Scholar
• Kimby E., Bjorkholm M., Gahrton G., Glimelius B., Hagberg H., Johansson B., Johansson H., Juliusson G., Jammark M., Lofvengerg E., Killander A., Lerner R., Lindemalm C., Petterson U., Robert K. H., Simonsson B., Stalfelt A. M., Sundstrom C., Svedmyr E., Uden A. M., Wadman B., Wahlin A., Ost A., Mellstedt H. Chlorambucil/Prednisone vs. CHOP In Symptomatic Low-Grade Non-Hodgkin's Lymphomas: a randomized trial from the lymphoma group of central Sweden. Annals of Oncology 1994; 5(supplement 2)S67–S71
   Google Scholar
• Johnson P. W. M., Rohatiner A. Z. S., Whelan J. S., Price C. G. A., Love S., Lim J., Matthews J., Norton A. J., Amess J. A. L., Lister T. A. Patterns of Survival in Patients with Recurrent Follicular Lymphoma: a 20-year study from a single centre. Journal of Clinical Oncology 1995; 13(1)140–147
   PubMed Web of Science ®Google Scholar
• Gallagher C. J., Gregory W. M., Jones A. E., Standfeld A. G., Richards M. A., Dhaliwal H. S., Malpas J. S., Lister T. A. Follicular Lymphoma: Prognostic Factors for Response and Survival. Journal of Clinical Oncology 1986; 10(4)1470–1480
   Google Scholar
• Spinolo J. A., Cabanillas F., Dixon E. O., Khorana S. M., McLaughlin P., Velasquez W. S., Hagemeister F. B., Redman J. R., Swan F. Therapy of Relapsed or Refractory Low-grade Follicular Lymphomas: factors associated with complete remission, survival and time to treatment failure. Annals of Oncology 1992; 3(3)227–232
   PubMed Web of Science ®Google Scholar
• Solal-Celigny P., Brice P., Brousse N., Caspard H., Bastion Y., Haioun C., Bosly A., Tilly H., Bordessoule D., Sebban C., Harousseau J. L., Morel P., Dupas B., Plassart F., Vasile N., Fort N., Leporrier M. Phase II Trial of Fludarabine Monophophate as First-Line Treatment in Patients with Advanced Follicular Lymphoma: a multicententer study by the Groupe d'Etude de Lymphomes de l'Adulte. Journal of Clinical Oncology 1996; 14(2)514–519
   PubMed Web of Science ®Google Scholar
• Belanger C., Solal-Celigny P., Brice P., Brousse N., Caspard H., Haioun C., Bosly A., Tilly H., Bordessoule D., Sebban C., Harousseau J. L., Morel P., Leporrier M. Fludarabine Monophosphate As First Line Therapy For Patients With Advanced Follicular Lymphoma: updated analysis of and salvage treatment results from the Groupe d'Etude de Lymphomes de l'Adulte (GELA) trial. Blood 1997; 90(10)344a, supplement 1
   Google Scholar
• Hagenbeek A., Eghbali H., Monfardini S., Resegotti E., Hoskin J., de Wolf-Peeters C., McLennan K., Teodorovic I., Anastasopoulou A., van Glabbeke M., Marcus R. Fludarabine versus Conventional CVP Chemotherapy in Newly Diagnosed Patients with Stage III and IV Low-Grade Malignant Non-Hodgkin's Lymphoma: preliminary results from a phase III clinical trial in 381 patients. Blood 1998; 92(10)315a, supplement 1
   Google Scholar
• Coiffier B., Stamatoulias A., Belanger C., Bouabdallah R., Haioun C., Neibhardt E. M., Brice P., Peaud P. L., Pico J. L., Janvier M., Solal-Celigny P., Brousse N. CHVP + Interferon α2b Treatment is Associated With a Longer Survival than Fludarabine alone in Elderly Patients with High Risk Follicular Lymphoraa: a randomized study form the GELA. Blood 1998; 92(10)486a, supplement 1
   Google Scholar
• Whelan J. S., Cavis C. L., Rule S., Ranson M., Smith O. P., Mehta A. B., Catovsky D., Rohatiner A. Z. S., Lister T. A. Fludarabine Phosphate for the Treatment of Low-Grade Lymphoid Malignancy. British Journal of Cancer 1991; 64(1)120–123
   PubMed Web of Science ®Google Scholar
• Hochster H. S., Kyungmann K., Green M. D., Mann R. B., Neimann R. S., Oken M. M., Cassileth P. A., Stott P., Ritch P., O'Connell M. J. Activity of Fludarabine in Previously Treated Non-Hodgkin's Low-Grade Lymphoma: results of an Eastern Cooperative Oncology Group study. Journal of Clinical Oncology 1992; 10(1)28–32
   PubMed Web of Science ®Google Scholar
• Redman J. R., Cabanillas F., Velasquez W. S., McLaughlin P., Hagemeister F. B., Swan F., Rodriguez M. A., Plunkett W. K., Keating M. J. Phase II Trial of Fludarabine Phosphate in Lymphoma: an effective new agent in low-grade lymphoma. Journal of Clinical Oncology 1992; 10(5)790–794
   PubMed Web of Science ®Google Scholar
• Hiddemann W., Unterhalt M., Pott C., Wormann B., Sandford D., Freund M., Engert A., Gassmann W., Holtkamp W., Seufert J., Hellriegel K. P., Knauf W., Emmerich B., Kanz L., Koch P. Fludarabine as Single Agent Therapy for Relapsed Low-grade NHL: a phase II study of the German low-grade non-Hodgkin's lymphoma study group. Seminars in Oncology 1993; 20(5)28–31, supplement 7
   PubMed Web of Science ®Google Scholar
• Pigaditou A., Rohatiner A. Z. S., Whelan J. S., Johnson P. W. M., Ganjoo R. K., Rossi A., Norton A. J. A., Aness J., Lim J., Lister T. A. Fludarabine In Low-Grade Lymphoma. Seminars in Oncology 1993; 20(5)24–27, supplement 7
   PubMed Web of Science ®Google Scholar
• Zinzani P. L., Lauria F., Rondelli D., Benfenati D., Raspadori D., Bocchia M., Bendandi M., Gozzetti A., Zaja F., Fanin R., Russo D., Galieni P., Tura S. Fludarabine: an active agent in the treatment of previously treated and untreated low-grade non-Hodgkin's lymphoma. Annals of Oncology 1993; 4: 575–579
   PubMed Web of Science ®Google Scholar
• O'Brien M. E. R., Matutes E., Cunningham D., Hill M., Emmett E., Ellis P. A., Milan S., Hickish T., Mercieca J., Catovsky D. Fludarabine In Lymphoproliferative Disorders: the Royal Marsden experience. Leukemia and Lymphoma 1994; 14(supplement 2)17–24
   PubMed Web of Science ®Google Scholar
• Zinzani P. L., Bendandi D., Magagnoli M., Rondelli D., de Vivo A., Benni M., Zamagni E., Cavo M., Tura S. Results of a Fludarabine Induction And α-Interferon Maintenance Protocol in Pre-Treated Patients with Chronic Lymphocytic Leukemia and Low-grade Non-Hodgkin's Lymphoma. European Journal of Hematology 1997; 59: 82–88
   PubMed Web of Science ®Google Scholar
• Gillis S., Dann E. J., Cass Y., Rochlemer R., Polliack A. Activity of Fludarabine in Refractory Chronic Lymphocytic Leukemia and Low-grade NHL: the Jerusalem experience. Leukemia and Lymphoma 1994; 15: 173–175
   PubMed Web of Science ®Google Scholar
• Falkson C. I. Fludarabine: a phase II trial in patients with previously treated low-grade lymphoma. American Journal of Clinical Oncology 1996; 19(3)268–270
   PubMed Web of Science ®Google Scholar
• Klasa R., Meyer R., Shustik C., Sawka C., Smith A., Grenier J. F., Berube S. (1999) Fludarabine versus CVP in previously treated patients with progressive low-grade non-Hodgkin's lymphomas. In American Society of Clinical Oncology Annual Meeting Summaries, 35th Annual Meeting, Atlanta, 1999, 35
   Google Scholar
• Oken M. M., Creech R. H., Tormey D. C., Horton J., Davis T. E., McFadden E. T., Carbone P. P. Toxicity And Response Criteria of the Eastern Cooperative Oncology Group. American Journal of Clinical Oncology 1982; 5(6)649–655
   PubMed Web of Science ®Google Scholar
• Steinberg A. J., Matutes A., Killick A. C., Wotherspoon S., Catovsky A. C., Lister T. A. Prolonged Disease-free Survival in Relapsed/Refractory Low-grade Lymphoma Treated with Fludarabine: a report of four cases. British Journal of Hematology 1998; 102: 532–534
   PubMed Web of Science ®Google Scholar